Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial
Rodbard, H. W., Cariou, B., Zinman, B., Handelsman, Y., Philis-Tsimikas, A., Skjøth, T. V., Rana, A., Mathieu, C.
Published in Diabetic medicine (01.11.2013)
Published in Diabetic medicine (01.11.2013)
Get full text
Journal Article
Web Resource
Efficacy and safety of once‐daily insulin degludec/insulin aspart compared with once‐daily insulin glargine in participants with Type 2 diabetes: a randomized, treat‐to‐target study
Kumar, S., Jang, H. C., Demirağ, N. G., Skjøth, T. V., Endahl, L., Bode, B.
Published in Diabetic medicine (01.02.2017)
Published in Diabetic medicine (01.02.2017)
Get full text
Journal Article
Effect of insulin degludec versus sitagliptin in patients with type 2 diabetes uncontrolled on oral antidiabetic agents
Philis-Tsimikas, A., Del Prato, S., Satman, I., Bhargava, A., Dharmalingam, M., Skjøth, T. V., Rasmussen, S., Garber, A. J.
Published in Diabetes, obesity & metabolism (01.08.2013)
Published in Diabetes, obesity & metabolism (01.08.2013)
Get full text
Journal Article
P1878Reduction in systolic blood pressure with semaglutide treatment is not due to weight loss alone: data from SUSTAIN 1-5
Bain, S, Davies, M, Knop, F K, Vrazic, H, Skjoth, T V, Lingvay, I
Published in European heart journal (01.08.2018)
Published in European heart journal (01.08.2018)
Get full text
Journal Article